Hyperglycemia, hyperinsulinemia, insulin resistance, and the risk of bph/luts severity and progression over time in community dwelling black men: The flint men's health study

Urology

Volumn 82, Issue 4, 2013, Pages 881-886

  Wallner, Lauren P ^a,b   Hollingsworth, John M ^a,b   Dunn, Rodney L ^a,b   Kim, Catherine ^a,b   Herman, William H ^a,b   Sarma, Aruna V ^a,b  

^a Kaiser Permanente Southern California ^*  (United States)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; INSULIN;

ADULT; AFRICAN AMERICAN; AGED; ARTICLE; BODY MASS; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE SEVERITY; GLUCOSE BLOOD LEVEL; GLUCOSE METABOLISM; GLYCEMIC CONTROL; HUMAN; HYPERGLYCEMIA; HYPERINSULINEMIA; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; LOWER URINARY TRACT SYMPTOM; MAJOR CLINICAL STUDY; METABOLIC DISORDER; OBESITY; PRIORITY JOURNAL; PROSTATE HYPERTROPHY; PROSTATE VOLUME;

ADULT; AFRICAN AMERICANS; AGED; DISEASE PROGRESSION; HUMANS; HYPERGLYCEMIA; HYPERINSULINISM; INSULIN RESISTANCE; LOWER URINARY TRACT SYMPTOMS; MALE; MIDDLE AGED; PROSTATIC HYPERPLASIA; RESIDENCE CHARACTERISTICS; RISK FACTORS; SEVERITY OF ILLNESS INDEX; TIME FACTORS;

EID: 84884988343     PISSN: 00904295     EISSN: 15279995     Source Type: Journal    
DOI: 10.1016/j.urology.2013.05.034     Document Type: Article

References (26)

1. J.T. Wei, E. Calhoun, and S.J. Jacobsen Urologic diseases in America project: benign prostatic hyperplasia J Urol 179 5 Suppl 2008 S75 S80
2. A.V. Sarma, J.K. Parsons, K. McVary, and J.T. Wei Diabetes and benign prostatic hyperplasia/lower urinary tract symptoms - what do we know? J Urol 182 6 Suppl 2009 S32 S37
3. W.M. Garraway, G.N. Collins, and R.J. Lee High prevalence of benign prostatic hypertrophy in the community Lancet 338 1991 469 471
4. S. Sidney, C. Quesenberry Jr., and M.C. Sadler Risk factors for surgically treated benign prostatic hyperplasia in a prepaid health care plan Urology 38 1 Suppl 1991 13 19
5. M.C. Michel, L. Mehlburger, and H. Schumacher Effect of diabetes on lower urinary tract symptoms in patients with benign prostatic hyperplasia J Urol 163 2000 1725 1729
6. A.V. Sarma, J.P. Burke, and D.J. Jacobson Associations between diabetes and clinical markers of benign prostatic hyperplasia among community-dwelling black and white men Diabetes Care 31 2008 476 482
7. J.K. Parsons, K. Messer, and M. White Obesity increases and physical activity decreases lower urinary tract symptom risk in older men: the Osteoporotic Fractures in Men study Eur Urol 60 2011 1173 1180
8. J.K. Parsons Modifiable risk factors for benign prostatic hyperplasia and lower urinary tract symptoms: new approaches to old problems J Urol 178 2007 395 401
9. E.S. Ford, W.H. Giles, and W.H. Dietz Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey JAMA 287 2002 356 359
10. M.C. Michel, U. Heemann, and H. Schumacher Association of hypertension with symptoms of benign prostatic hyperplasia J Urol 172 4 Pt 1 2004 1390 1393
11. D.F. Penson, H.M. Munro, and L.B. Signorello Obesity, physical activity and lower urinary tract symptoms: results from the Southern Community Cohort Study J Urol 186 2011 2316 2322
12. A.V. Sarma, J.T. Wei, and D.J. Jacobson Comparison of lower urinary tract symptom severity and associated bother between community-dwelling black and white men: the Olmsted County Study of Urinary Symptoms and Health Status and the Flint Men's Health Study Urology 61 2003 1086 1091
13. M.C. Marshall Jr. Diabetes in African Americans Postgrad Med J 81 2005 734 740
14. J.T. Wei, D. Schottenfeld, and K. Cooper The natural history of lower urinary tract symptoms in black American men: relationships with aging, prostate size, flow rate and bothersomeness J Urol 165 2001 1521 1525
15. K. Kato, Y. Umeda, and F. Suzuki Evaluation of a solid-phase enzyme immunoassay for insulin in human serum Clin Chem 25 1979 1306 1308
16. D.R. Matthews, J.P. Hosker, and A.S. Rudenski Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man Diabetologia 28 1985 412 419
17. M.J. Barry, F.J. Fowler Jr., and M.P. O'Leary The American Urological Association symptom index for benign prostatic hyperplasia. The Measurement Committee of the American Urological Association J Urol 148 1992 1549 1557 [discussion: 1564]
18. S.J. Jacobsen, D.J. Jacobson, and C.J. Girman Treatment for benign prostatic hyperplasia among community dwelling men: the Olmsted County study of urinary symptoms and health status J Urol 162 1999 1301 1306
19. J.K. Parsons, H.B. Carter, and A.W. Partin Metabolic factors associated with benign prostatic hyperplasia J Clin Endocrinol Metab 91 2006 2562 2568
20. J. Hammarsten, and B. Högstedt Hyperinsulinaemia as a risk factor for developing benign prostatic hyperplasia Eur Urol 39 2001 151 158
21. S.E. Dahle, A.P. Chokkalingam, and Y. Gao Body size and serum levels of insulin and leptin in relation to the risk of benign prostatic hyperplasia J Urol 168 2002 599 604
22. S. Rohrmann, E. Smit, E. Giovannucci, and E.A. Platz Association between markers of the metabolic syndrome and lower urinary tract symptoms in the Third National Health and Nutrition Examination Survey (NHANES III) Int J Obes (Lond) 29 2005 310 316
23. A.V. Sarma, J.L. St Sauver, and J.M. Hollingsworth Diabetes treatment and progression of benign prostatic hyperplasia in community-dwelling black and white men Urology 79 2012 102 108
24. S. Rohrmann, E.A. Platz, and E. Giovannucci Lifestyle and benign prostatic hyperplasia in older men: what do we know? J Mens Health Gend 2 2005 230 235
25. A.V. Sarma, C.A. Jaffe, and D. Schottenfeld Insulin-like growth factor-1, insulin-like growth factor binding protein-3, and body mass index: clinical correlates of prostate volume among black men Urology 59 2002 362 367
26. P. Cohen, D.M. Peehl, and R.G. Rosenfeld The IGF axis in the prostate Horm Metab Res 26 1994 81 84